Lead StrategistMC2 Therapeutics A/S
Company details
- CVR number
- 29526346
- Status
- Active
- Legal form
- Public limited company (A/S)
- Industry
- Fremstilling af farmaceutiske præparater(212000)
- Founded
- 4 May 2006
- Address
- Agern Alle 24-26, 2970 Hørsholm
- Municipality
- Rudersdal
Find similar companies in the same industry and build a lead list right inside your AI.
Key figures
The latest 3 financial years from the annual reports. Amounts in Danish kroner (DKK).
| Financial year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Gross profit | DKK 22.2m | DKK 24.5m | DKK 26.4m |
| Net profit | −DKK 7.8m | −DKK 53.0m | −DKK 41.9m |
| Equity | −DKK 224.5m | −DKK 218.4m | −DKK 164.5m |
| Employees (avg.) | 11 | 15 | 15 |
Track the trend via the API.REST API (OpenAPI)
Get all 6 years of financials right inside Claude or ChatGPT via MCP.
Similar companies
Other active companies in Fremstilling af farmaceutiske præparater in Rudersdal, close in size (employees and gross profit).
- ALK-ABELLÓ A/S
2970 Hørsholm
2,737 employees · gross profit DKK 4.2bn (2025)
- Allarity Therapeutics Europe ApS
2970 Hørsholm
4 employees · gross profit -DKK 39.0m (2025)
- Breye Therapeutics ApS
2970 Hørsholm
3 employees · gross profit -DKK 7.7m (2026)
- SCANPHARM A/S
3460 Birkerød
gross profit DKK 29.7m (2025)
- Remecure ApS
2840 Holte
gross profit DKK 9k (2025)
- Allarity Therapeutics Denmark ApS
2970 Hørsholm
gross profit DKK 0 (2025)
- SYNACT PHARMA ApS
2840 Holte
gross profit -DKK 53.2m (2025)
- Blonor Pharma ASA
2840 Holte
See all:Fremstilling af farmaceutiske præparater (178)Rudersdal (8,759)
Full financials and history
Lead Strategist is free during the beta with 20,000 credits a month. Get every figure for this company right inside your AI or via the API.
- All 6 financial years in the database
- Balance sheet: assets, liabilities, provisions and cash
- EBIT, gross profit and reporting class
- Auditor and audit firm
Free beta · 20,000 credits a month · no card
By creating an account you accept the terms on behalf of your business.